Cleared Traditional

K964025 - MITAYA ALUMINUM INTERSPACED X-RAY GRID (FDA 510(k) Clearance)

Class I Radiology device.

K964025 · X-Ray Accessory Corp. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1997
Decision
249d
Days
Class 1
Risk

K964025 is an FDA 510(k) clearance for the MITAYA ALUMINUM INTERSPACED X-RAY GRID. Classified as Grid, Radiographic (product code IXJ), Class I - General Controls.

Submitted by X-Ray Accessory Corp. (Danielson, US). The FDA issued a Cleared decision on June 13, 1997 after a review of 249 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1910 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all X-Ray Accessory Corp. devices

Submission Details

510(k) Number K964025 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 07, 1996
Decision Date June 13, 1997
Days to Decision 249 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
142d slower than avg
Panel avg: 107d · This submission: 249d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code IXJ Grid, Radiographic
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 892.1910
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.